Regulatory Intelligence for Medical Devices
Engineer regulatory excellence with Masuu’s Medical Device Regulatory Intelligence.
Global Regulatory Intelligence for Medical Devices: We transform complex, fast changing global regulations into actionable insights—empowering your innovations to stay safe, compliant, and future ready in every market.
With Masuu, your devices don’t just enter global markets they lead them.
From Complexity to Clarity: NextGeneration Regulatory Intelligence
The global medical device ecosystem is evolving rapidly. Whether your product is:- High risk or low risk
- Software based or hardware-driven
- A standalone device or a combination product
Every category must comply with stringent regulatory expectations that govern safety, performance, labeling, QMS, and post market oversight.
Manufacturers face constant challenges:
- Interpreting multicounty regulatory frameworks
- Keeping pace with evolving MDR/IVDR, FDA QMSR, MHRA reforms, TGA updates, MDSAP changes
- Correctly classifying devices for each market
- Ensuring labeling, UDI, and artwork compliance
- Tracking post market surveillance (PMS) and vigilance rules
- Managing global submissions & registration cycles
Masuu Global Solutions delivers a complete Regulatory Intelligence ecosystem that simplifies your compliance journey.
Masuu’s Regulatory Intelligence Platform & Services
We combine configurable software tools with expert regulatory consulting to give medical device companies real time clarity, accuracy, and control over multicounty requirements.
Our intelligence framework supports you across:
- Device Classification: Risk class mapping across 120+ markets
- Global Registration Pathways: Market specific requirements for dossiers, testing, safety, and timelines
- Labeling & UDI Requirements: Region specific rules for symbols, language, artwork, and identifiers
- Technical Documentation Expectations: MDR/IVDR, FDA, UKCA, TGA, and global standards
- Regulatory Standards Monitoring: ISO, IEC, IMDRF, GHTF, and national guidance updates
- Post Market Surveillance: Global vigilance rules, adverse event reporting, and trending obligations
- Clinical & Performance Evidence: Requirements for CER, PER, PMCF, PMPF
- Combination Products & Digital Health: AI/ML enabled devices, SaMD classification, software rules
Unmatched Global Coverage
Masuu provides access to 5000+ regulatory insights, categorized by:- Risk class
- Product type
- Therapy area
- Geography
- Technology (SaMD, AI/ML, IVD, electro-medical devices, implants, wearables, etc.)
Our intelligence engine covers regulations governing:
- Drug–Device Combination Products
- In Vitro Diagnostics (IVDs)
- Digital Health & SaMD
- AI enabled Medical Devices
- Traditional medical devices across sterile, implantable, reusable, and consumable categories
We help startups, scaleups, and enterprise manufacturers navigate the global regulatory landscape with clarity and confidence.
Benefits of Masuu’s Regulatory Intelligence
- Always Be One Step Ahead Stay updated with regulatory changes that affect safety, submissions, QMS, labeling, and postmarket processes.
- Accelerate Market Access Minimize delays with accurate, realtime insights for registration pathways and compliance requirements.
- Reduce Regulatory Risk Avoid errors, rework, and rejection by using validated, expertcurated intelligence.
- Strengthen Global Strategy Make informed decisions about product portfolio expansion, market prioritization, and investment planning.
- End to End Lifecycle Support From concept development to post market compliance, Masuu ensures uninterrupted regulatory readiness.
Why Choose Masuu Global Solutions?
- Deep understanding of global medical device regulatory ecosystems
- Intelligence covering 120+ countries and all major authorities
- Expertise across device, IVD, SaMD, & combination product pathways
- Continuous monitoring of regulations, guidance updates, and HA announcements
- Trusted by manufacturers for strategic, accurate, and practical insights
- Tailored intelligence aligned with your device type and business model
Frequently Asked Questions
Medical device regulatory intelligence involves systematically monitoring and interpreting regulations, guidance, standards, and regulatory authority updates that affect a product. It helps manufacturers understand changing requirements for classification, registration, technical documentation, labeling, quality systems, clinical evidence, post-market surveillance, and other compliance activities across different markets.
Regulatory intelligence helps manufacturers identify country-specific registration pathways, documentation requirements, testing expectations, regulatory timelines, and authority requirements before entering a market. Comparing these requirements across countries can help manufacturers prioritize markets, identify documentation gaps, plan submissions, and adapt their regulatory strategy to different jurisdictions.
Manufacturers can monitor regulatory authority announcements, new regulations, guidance documents, standards, consultation updates, and changes to registration or post-market requirements. A structured regulatory intelligence process organizes these changes by country, product type, and regulatory topic, making it easier to determine which updates require action for specific medical devices.
Device classification can differ between regulatory jurisdictions, even when the same product is marketed globally. Regulatory intelligence helps manufacturers compare classification rules and identify the applicable risk category in each target market. This is important because classification can determine the conformity assessment route, clinical evidence, technical documentation, registration process, and post-market requirements.
Labeling and UDI requirements can vary by market, including rules for symbols, languages, identifiers, packaging information, and artwork. Regulatory intelligence helps manufacturers track these country-specific requirements and regulatory changes so that labeling and UDI information can be adapted appropriately before registration, commercialization, or implementation of regulatory updates.
Regulatory intelligence can be used to monitor changes in post-market surveillance, vigilance, adverse-event reporting, safety communication, and trending requirements across different markets. Tracking these obligations helps manufacturers identify new responsibilities, update PMS processes, and maintain compliance after a medical device has been placed on the market.
SaMD may be subject to requirements covering software classification, technical documentation, clinical or performance evidence, cybersecurity, quality systems, and post-market monitoring. Regulatory intelligence helps manufacturers compare these requirements across jurisdictions and monitor changes affecting software-based medical devices, including emerging rules for digital health and AI-enabled technologies.
AI-enabled medical devices can be affected by requirements covering device classification, software lifecycle processes, clinical evidence, risk management, performance monitoring, and post-market oversight. Regulatory intelligence helps manufacturers monitor evolving national and international expectations and determine how regulatory developments may affect product development, technical documentation, submissions, and lifecycle compliance.
IVDs and drug-device combination products can follow regulatory pathways that differ from conventional medical devices. Regulatory intelligence helps manufacturers identify applicable regulations, classification criteria, evidence requirements, submission pathways, labeling expectations, and post-market obligations. Monitoring jurisdiction-specific developments is particularly important when requirements differ across target markets.
Regulatory intelligence can reduce regulatory risk by identifying changes and country-specific requirements before they create submission or compliance problems. Manufacturers can use this information to detect documentation gaps, anticipate regulatory changes, update labeling or QMS processes, adjust registration strategies, and maintain regulatory readiness throughout the product lifecycle.